Literature DB >> 7503666

An intraperitoneal tumorous mass caused by granulomas of microfibrillar collagen hemostat (Avitene).

M Nakajima1, T Kamei, K Tomimatu, T Manabe.   

Abstract

Microfibrillar collagen hemostat (Avitene) is an absorbable topical hemostatic agent prepared from purified bovine corium collagen. Herein, we report the case of a 56-year-old woman who had undergone an ovariohysterectomy for an ovarian mucinous cystadenocarcinoma 3 months previously and then required a second operation for an intraperitoneal mass associated with microfibrillar collagen hemostat. Microscopically, the resected mass was composed mostly of foreign-body granulomas with microfibrillar collagen hemostat materials. Microfibrillar collagen hemostat was used to control bleeding during the first operation. In a very small portion, however, a recurrent mucinous cystadenocarcinoma was also present. This case is worthy of note in that microfibrillar collagen hemostat may produce huge granulomatous masses that clinically mimic a neoplasm, inducing unnecessary and extensive treatment.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7503666

Source DB:  PubMed          Journal:  Arch Pathol Lab Med        ISSN: 0003-9985            Impact factor:   5.534


  11 in total

Review 1.  Clinical benefits and risk analysis of topical hemostats: a review.

Authors:  Yasuko Tomizawa
Journal:  J Artif Organs       Date:  2005       Impact factor: 1.731

2.  A retrospective cohort study of hemostatic agent use during hysterectomy and risk of post-operative complications.

Authors:  John A Harris; Shitanshu Uppal; Neil Kamdar; Carolyn W Swenson; Darrell Campbell; Daniel M Morgan
Journal:  Int J Gynaecol Obstet       Date:  2016-11-16       Impact factor: 3.561

3.  Granulomatous meningitis secondary to Avitene (microfibrillar collagen).

Authors:  Swetha Renati; Supreet Kaur; Jesse L Kresak; Meredith Wicklund; Irene Malaty
Journal:  Neurol Clin Pract       Date:  2017-10

4.  Anaphylaxis after injecting a hemostatic agent containing gelatin into vertebral bone under pressure-a warning.

Authors:  Sean Bonanni; Brittany L Sipp; Richard M Schwend
Journal:  Spine Deform       Date:  2021-01-18

Review 5.  Use of Monsel solution to treat obstetrical hemorrhage: a review and comparison to other topical hemostatic agents.

Authors:  Devin T Miller; Dana M Roque; Alessandro D Santin
Journal:  Am J Obstet Gynecol       Date:  2015-01-08       Impact factor: 8.661

6.  Radiculopathy due to microfibrillar collagen hemostat mimicking recurrence of disc herniation.

Authors:  M Doita; K Nishida; M Kurosaka
Journal:  Skeletal Radiol       Date:  2006-03-16       Impact factor: 2.199

7.  Caseating granulomata caused by hemostatic agent posing as metastatic leiomyosarcoma.

Authors:  Abraham R Shashoua; Diana Gill; Ramon Barajas; Morteza Dini; Carey August; Gary L Kirschenbaum; Liza Escuardro
Journal:  JSLS       Date:  2009 Apr-Jun       Impact factor: 2.172

8.  Safety and effectiveness of a synthetic hemostatic patch for intraoperative soft tissue bleeding.

Authors:  Christoph Schuhmacher; Johann Pratschke; Sascha Weiss; Stefan Schneeberger; André L Mihaljevic; Rebekka Schirren; Michael Winkler; Nikos Emmanouilidis
Journal:  Med Devices (Auckl)       Date:  2015-03-31

9.  Postoperative aseptic intracranial granuloma: the possible influence of fluid hemostatics.

Authors:  Mario Ganau; Nicola Nicassio; Leonello Tacconi
Journal:  Case Rep Surg       Date:  2012-08-09

Review 10.  Topical biomaterials to prevent post-tonsillectomy hemorrhage.

Authors:  Lumei Liu; Cole Rodman; Noah E Worobetz; Jed Johnson; Charles Elmaraghy; Tendy Chiang
Journal:  J Otolaryngol Head Neck Surg       Date:  2019-09-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.